1. A combination of circulating microRNA-375-3p and chemokines CCL11, CXCL12, and G-CSF differentiate Crohn’s disease and intestinal tuberculosis
- Author
-
Mallica Banerjee, Sayantan Laha, Gopal Krishna Dhali, Aniket Halder, Rajib Sarkar, Soma Banerjee, Suchandrima Ghosh, Alakendu Ghosh, Susree Roy, Simanti Datta, Dipanjan Bhattacharjee, Ranajoy Ghosh, Arko Banerjee, Raghunath Chatterjee, and Sujay Ray
- Subjects
Adult ,Chemokine CCL11 ,Male ,medicine.medical_specialty ,Chemokine ,medicine.medical_treatment ,Science ,Gastroenterology ,Article ,Diagnosis, Differential ,Transcriptome ,Young Adult ,Crohn Disease ,Internal medicine ,Granulocyte Colony-Stimulating Factor ,microRNA ,medicine ,Humans ,Gastrointestinal diseases ,CCL11 ,Crohn's disease ,Multidisciplinary ,biology ,business.industry ,Diagnostic markers ,Middle Aged ,medicine.disease ,Chemokine CXCL12 ,MicroRNAs ,Circulating MicroRNA ,Cytokine ,Tuberculosis, Gastrointestinal ,biology.protein ,Biomarker (medicine) ,Medicine ,Female ,business ,Biomarkers - Abstract
Differentiation of Crohn’s disease (CD) from intestinal tuberculosis (ITB) is a big challenge to gastroenterologists because of their indistinguishable features and insensitive diagnostic tools. A non-invasive biomarker is urgently required to distinguish ITB/CD patients particularly in India, a TB endemic region, where CD frequency is increasing rapidly due to urbanization. Among the three differentially expressed miRNAs obtained from small RNA transcriptomic profiling of ileocaecal/terminal ileal tissue of ITB/CD patients (n = 3), only two down-regulated miRNAs, miR-31-5p, and miR-215-5p showed comparable data in qRT-PCR. Out of which, only miR-215-5p was detectable in the patient’s plasma, but there was no significant difference in expression between ITB/CD. On the other hand, miR-375-3p, the pulmonary TB specific marker was found in higher amount in the plasma of ITB patients than CD while reverse expression was observed in the ileocaecal/terminal ileal tissues of the same patients. Next, using Bioplex pro-human cytokine 48-plex screening panel, only three chemokines, Eotaxin-1/CCL11, SDF-1α/CXCL12, and G-CSF have noted significantly different levels in the serum of ITB/CD patients. ROC analysis has revealed that compared to a single molecule, a combination of miR-375-3p + Eotaxin-1/CCL11 + SDF-1α /CXCL12 + G-CSF showed a better AUC of 0.83, 95% CI (0.69–0.96) with 100% specificity and positive predictive value while sensitivity, negative predictive value, and accuracy were 56%, 69%, and 78% respectively in distinguishing ITB from CD. This study suggests that a combination of plasma markers shows better potential in differentiating ITB from CD than a single marker and this panel of markers may be used for clinical management of ITB/CD patients.
- Published
- 2021